CRUK RadNet Birmingham

The radiation research network (RadNet), funded by Cancer Research UK, is a collaborative network of seven centres of excellence across the UK focussed on radiation biology and oncology research. The collective goal is to make radiotherapy more effective and safer for patients with specific tumour types.

RadNet Birmingham received funding from Cancer Research UK in 2024 and officially launched in 2025. Over the next 5 years, our mission is to harness our unique ecosystem of fundamental science, radiation biology, medical physics and oncology, along with the network of institutions, to unlock the full potential of novel radiotherapy technologies and deliveries.

  • Our vision

    We will explore the biological impact of proton beam therapy and other more effective radiotherapies which can be exploited for the treatment of specific cancers.

    We will also use the new knowledge generated to provide a basis for future national decisions that will improve patient outcome and reduced treatment toxicities following radiotherapy.

Explore CRUK RadNet Birmingham

Our PPIE members

Meet our PPIE members

About our PPIE members

At CRUK RadNet Birmingham, we want to ensure that improving the patient experience is at the centre of all of our research. To achieve this, we will use Patient and Public Involvement and Engagement (PPIE) to ensure that the voice of patients and members of the public are heard at every stage of the research process.

We believe that integrating PPIE into the research process as early as possible is highly important, as it can otherwise feel like there is a long way between experiments done in a laboratory and treating patients in the clinic. PPIE gives patients a chance to influence research by speaking to scientists about their work, and how it relates to the ultimate end goal of improving treatments. This can include influencing the topics studied, how the studies are designed, and how information is communicated to patients and the public.

We plan to get our PPIE group involved in the research and outreach in several ways.

  • We will create forums for scientists to pitch their work so we can collaborate to achieve the end goal.
  • We will also do community outreach to patients currently going through treatment.

Patient and public involvement and engagement lead

Ms Lucy Speechley

 

Patients

TBC